DD159737A5 - Verfahren zur herstellung von protrohiert wirkenden vincamin-zubereitungen - Google Patents
Verfahren zur herstellung von protrohiert wirkenden vincamin-zubereitungen Download PDFInfo
- Publication number
- DD159737A5 DD159737A5 DD81231010A DD23101081A DD159737A5 DD 159737 A5 DD159737 A5 DD 159737A5 DD 81231010 A DD81231010 A DD 81231010A DD 23101081 A DD23101081 A DD 23101081A DD 159737 A5 DD159737 A5 DD 159737A5
- Authority
- DD
- German Democratic Republic
- Prior art keywords
- vincamine
- preparations
- salt
- item
- cation exchange
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
- A61K47/585—Ion exchange resins, e.g. polystyrene sulfonic acid resin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D461/00—Heterocyclic compounds containing indolo [3,2,1-d,e] pyrido [3,2,1,j] [1,5]-naphthyridine ring systems, e.g. vincamine
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cardiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Saccharide Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH480480 | 1980-06-23 |
Publications (1)
Publication Number | Publication Date |
---|---|
DD159737A5 true DD159737A5 (de) | 1983-04-06 |
Family
ID=4282830
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DD81231010A DD159737A5 (de) | 1980-06-23 | 1981-06-22 | Verfahren zur herstellung von protrohiert wirkenden vincamin-zubereitungen |
Country Status (15)
Country | Link |
---|---|
EP (1) | EP0042818A1 (el) |
JP (1) | JPS5762277A (el) |
KR (1) | KR830005853A (el) |
AU (1) | AU7201781A (el) |
DD (1) | DD159737A5 (el) |
DK (1) | DK274081A (el) |
ES (1) | ES8203891A1 (el) |
FI (1) | FI811934L (el) |
GB (1) | GB2078758A (el) |
GR (1) | GR75708B (el) |
IL (1) | IL63148A0 (el) |
NO (1) | NO812039L (el) |
NZ (1) | NZ197485A (el) |
PT (1) | PT73238B (el) |
ZA (1) | ZA814194B (el) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES8604955A1 (es) * | 1985-11-08 | 1986-03-16 | Covex Sa | Procedimiento para la preparacion de resinatos de la (-) eburnamenina-14-(15h)-ona |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE550150A (el) * | 1955-08-08 | |||
FR2201898A1 (en) * | 1973-05-30 | 1974-05-03 | Sogeras | Vincamine arabogalactan sulphate - with prolonged activity for treating cerebrovascular disorders |
FR2253507A1 (en) * | 1973-12-11 | 1975-07-04 | Houdet Antoine | Vincamine administration using delayed release excipient - allowing prolonged action |
FR2313915A1 (fr) * | 1976-01-26 | 1977-01-07 | Corneille Gilbert | Nouvelle forme galenique d'administration de la vincamine et de ses derives, son procede de preparation et medicaments comprenant cette nouvelle forme |
PT66201B (fr) * | 1976-02-23 | 1978-11-07 | Corvi Mora E | Procede et composition pour la therapeutique des maladies circulatoires cerebrales |
-
1981
- 1981-05-30 JP JP56081923A patent/JPS5762277A/ja active Pending
- 1981-06-15 GB GB8118289A patent/GB2078758A/en not_active Withdrawn
- 1981-06-16 NO NO812039A patent/NO812039L/no unknown
- 1981-06-17 EP EP81810248A patent/EP0042818A1/de not_active Withdrawn
- 1981-06-18 FI FI811934A patent/FI811934L/fi not_active Application Discontinuation
- 1981-06-22 PT PT73238A patent/PT73238B/pt unknown
- 1981-06-22 ES ES503263A patent/ES8203891A1/es not_active Expired
- 1981-06-22 GR GR65301A patent/GR75708B/el unknown
- 1981-06-22 ZA ZA814194A patent/ZA814194B/xx unknown
- 1981-06-22 IL IL63148A patent/IL63148A0/xx unknown
- 1981-06-22 AU AU72017/81A patent/AU7201781A/en not_active Abandoned
- 1981-06-22 NZ NZ197485A patent/NZ197485A/xx unknown
- 1981-06-22 DD DD81231010A patent/DD159737A5/de unknown
- 1981-06-22 DK DK274081A patent/DK274081A/da not_active Application Discontinuation
- 1981-06-23 KR KR1019810002271A patent/KR830005853A/ko unknown
Also Published As
Publication number | Publication date |
---|---|
GB2078758A (en) | 1982-01-13 |
NZ197485A (en) | 1983-09-30 |
GR75708B (el) | 1984-08-02 |
EP0042818A1 (de) | 1981-12-30 |
FI811934L (fi) | 1981-12-24 |
NO812039L (no) | 1981-12-28 |
JPS5762277A (en) | 1982-04-15 |
ES503263A0 (es) | 1982-04-01 |
PT73238B (de) | 1983-05-11 |
AU7201781A (en) | 1982-01-07 |
KR830005853A (ko) | 1983-09-14 |
PT73238A (de) | 1981-07-01 |
ZA814194B (en) | 1982-07-28 |
ES8203891A1 (es) | 1982-04-01 |
IL63148A0 (en) | 1981-09-13 |
DK274081A (da) | 1981-12-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE3852781T2 (de) | Präparat mit verzögerter Freisetzung sowie dessen Herstellung. | |
EP1390023B1 (de) | Pharmazeutische salze von 1-phenyl-3-dimethylamino-propan-verbindungen | |
DE69323428T2 (de) | Morphinzubereitungen mit kontrollierter freisetzung | |
EP1207868B1 (de) | Pharmazeutische tramadolsalze | |
DE69830728T2 (de) | Arzneimittel zur behandlung von häufigem wasserlassen und harninkontinenz | |
DD146547A5 (de) | Arzneimittel-retardform mit unloeslichen poroesen diffusionshuellen | |
EP1435915B1 (de) | Orale darreichungsformen für propiverin oder seinen pharmazeutisch annehmbaren salzen mit verlängerter wirkstofffreisetzung | |
DE60202615T2 (de) | Kristalline zusammensetzung mit escitalopram | |
DD218373A5 (de) | Verfahren zur herstellung eines resinates einer substituierten carbonsaeure | |
EP0386440A1 (de) | Arzneimittel mit kontrollierter Wirkstoffabgabe | |
DD292374A5 (de) | Verfahren zum herstellen von ueberzugsmaterialien zur steuerung der arzneimittelfreisetzung bei langzeitwirkenden zubereitungen | |
DE69919155T2 (de) | Formulierungen zur mehrfachfreisetzung | |
DE1908946A1 (de) | Pharmazeutische Praeparate und Verfahren zur Herstellung derselben | |
CH634561A5 (de) | Verfahren zur herstellung von neuen 1-nitro-9-dialkylaminoisoalkylaminoacridinen. | |
US4369175A (en) | Process for the manufacture of prolonged action vincamine preparations, the vincamine preparations so obtained, and medicaments containing them | |
DD159737A5 (de) | Verfahren zur herstellung von protrohiert wirkenden vincamin-zubereitungen | |
DE2950154C2 (el) | ||
DE3034975C2 (de) | Arzneimittelkombination zur Behandlung infektiöser Atemwegerkrankungen | |
DE69005993T2 (de) | Verfahren zur Herstellung eines Ranitidin-Harz-Absorbates. | |
DE2300614A1 (de) | Neue optisch aktive verbindungen | |
EP0192098B1 (de) | Verwendung des 2-Amino-6-allyl-5,6,7,8-tetrahydro-4H-thiazolo[4,5-d]azepins zur Herstellung eines zur Behandlung der Parkinsonschen Erkrankung bzw. des Parkinsonismus geeigneten Arzneimittels | |
DE602005004033T2 (de) | Venlafaxin enthaltende pharmazeutische teilchenförmige zusammensetzung mit verzögerter freisetzung | |
DE2100269C3 (el) | ||
DE19714024A1 (de) | Verfahren zur Herstellung von gering dosierten freifließenden und/oder direktkomprimierbaren Pulversystemen | |
DE2362783C2 (de) | Pharmazeutisches Kombinationspräparat zur Behandlung von Rhinitis |